Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis.

Authors :: Catzola V
Battaglia A
Buzzonetti A
Fossati M
Scuderi F
Fattorossi A
Evoli A
Source :: Journal of neurology [J Neurol] 2013 Aug; Vol. 260 (8), pp. 2163-5. Date of Electronic Publication: 2013 Jun 08.
Publication Year :: 2013

Subjects :: Adult
Female
Humans
Middle Aged
Myasthenia Gravis immunology
Receptor Protein-Tyrosine Kinases immunology
Receptors, Cholinergic immunology
Rituximab
Antibodies, Monoclonal, Murine-Derived therapeutic use
Immunosuppressive Agents therapeutic use
Myasthenia Gravis drug therapy
T-Lymphocytes, Regulatory drug effects

Full Text Access

Tools